This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Respiratory Tract Infections or Urinary Tract Infections
and you are
between 18 and 70
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

In the proposed study, the investigators plan to evaluate the efficacy and safety of Ceftazidime Sodium and Sulbactam Sodium for Injection(2:1) for the treatment of respiratory and urinary tract acute bacterial infection.

Provided treatments

  • Drug: High dose
  • Drug: Low dose
  • Drug: Cefoperazone and Sulbactam Sodium (CFP/SUB)
Tris trial is registered with FDA with number: NCT01601093. The sponsor of the trial is Xiangbei Welman Pharmaceutical Co., Ltd and it is looking for 288 volunteers for the current phase.
Official trial title:
Phase Ⅱ Study on Ceftazidime Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection